FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Thursday

 

Off Label Medications now available for MS: VIDEO






















More than 6,500 Connecticut residents are affected by multiple sclerosis, a chronic, often disabling disease of the central nervous system.

The cause is unknown and there is currently no cure for MS. Symptoms can include numbness in the limbs, difficulties with vision and speech, stiffness, loss of mobility and, in some more severe cases, total paralysis. The progress, severity, and specific symptoms of MS in any one person cannot be predicted.

Coverage of Off-Label Prescriptions

“Off-label” prescriptions are medications that are being used in a manner not specified in the FDA’s approved packaging label, or insert. The practice, called “off-label” prescribing, is entirely legal and very common. More than one in five outpatient prescriptions written in the U.S. are for off-label therapies.

Off-label prescribing can be beneficial, especially when patients have exhausted all other approved options, as may be the case with cancer or other disabling or life-threatening diseases such as multiple sclerosis.

Many insurance companies will not pay for an expensive drug that’s used in a way that’s not listed in the approved drug label. They do this on the grounds that its use is “experimental” or “investigational.”  Many states, including Connecticut, have laws safeguarding coverage for patients with disabling, chronic or life-threatening conditions. In Connecticut, health insurers were prevented from denying coverage of off-label medications if the drug had been recognized by one of three standard medical references. However, two of the three compendia are no longer published.

The legislation that went into effect January 1, 2016, broadened the references by adding “peer-reviewed medical literature.” This addition gives physicians greater power to prescribe off-label  drugs without the concern of rejection by their patients’ insurers.

Story Source: The above story is based on materials provided by CTSTYLE
Note: Materials may be edited for content and length


Labels:



Go to Newer News Go to Older News